Genetic Signatures Limited

ASX:GSS Stock Report

Market Cap: AU$126.8m

Genetic Signatures Limited Company Information

Genetic Signatures Limited's employee growth, exchange listings and data sources


Key Information

  • Name: Genetic Signatures Limited
  • Ticker: GSS
  • Exchange: ASX
  • Founded: 2001
  • Industry: Life Sciences Tools and Services
  • Sector: Pharmaceuticals & Biotech
  • Market Cap: AU$126.811m
  • Shares Outstanding: 186.49m
  • Website: https://www.geneticsignatures.com

Number of Employees


Location

  • Genetic Signatures Limited
  • Heart Research Institute
  • 7 Eliza Street
  • Newtown
  • New South Wales
  • 2042
  • Australia


Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
GSSASX (Australian Securities Exchange)YesOrdinary SharesAUAUDMar 2015
GSSCHIA (Chi-X Australia)YesOrdinary SharesAUAUDMar 2015

Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2024/03/28 00:00
End of Day Share Price 2024/03/28 00:00
Earnings2023/12/31
Annual Earnings2023/06/30


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.